Literature DB >> 26254301

Early Failure of Dialysis Access among the Elderly in the Era of Fistula First.

Karen Woo1, Dana P Goldman2, John A Romley3.   

Abstract

BACKGROUND AND OBJECTIVES: Recent evidence indicates that fistula maturation and patency may be compromised in the elderly dialysis population compared with younger patients. The objective of this study was to characterize the short-term outcomes of arteriovenous fistulas and arteriovenous grafts for hemodialysis access in the Medicare population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a retrospective cohort study performed using Medicare Part A and B claims data from 2006 through 2011. The study population included 16,464 dialysis-dependent patients age ≥66 years undergoing arteriovenous fistula and arteriovenous graft creation. The primary outcome measure was incidence of repeat fistula/graft creation and tunneled catheter placements in the 12 months after arteriovenous fistula and graft creation.
RESULTS: In the 12 months postindex fistula/graft, the mortality in the fistula group was 28.2% versus 29.9% in the graft group (P=0.03). A repeat fistula/graft creation was required in 26.9% of patients in the fistula group and 16.7% in the graft group (P<0.001). There was no significant difference in the proportion of patients who required a tunneled hemodialysis catheter in the 12 months after an index fistula creation (fistula 28.4% versus graft 27.3%, P=0.19). In the index fistula group, 44.4% of patients required a repeat fistula/graft creation and/or a tunneled catheter, compared with 33.7% in the graft group (P<0.001). At 365 days after the index fistula/graft, the repeat fistula/graft/catheter-free survival was 39.7% in the fistula group versus 46.0% in the graft group (P<0.001). Index fistula was associated with a higher risk of loss of repeat fistula/graft/catheter-free survival with an odds ratio of 1.19 (95% confidence interval, 1.13 to 1.24).
CONCLUSIONS: Fistulas were associated with a somewhat lower mortality than grafts in the first 12 months after creation. However, the incidence of repeat fistula/graft creation and tunneled catheter placement is substantially higher in the first 12 months after fistula creation compared with grafts. One-year repeat fistula/graft/catheter-free survival is lower after fistula creation than grafts.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  ESRD; Medicare claims; arteriovenous shunt; geriatric nephrology; surgical failure

Mesh:

Year:  2015        PMID: 26254301      PMCID: PMC4594075          DOI: 10.2215/CJN.09040914

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  22 in total

1.  III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000.

Authors: 
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  "Fistula first" initiative pushes for new standards in access care.

Authors:  Mark E Neumann
Journal:  Nephrol News Issues       Date:  2004-08

3.  Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study.

Authors:  K D Gibson; D L Gillen; M T Caps; T R Kohler; D J Sherrard; C O Stehman-Breen
Journal:  J Vasc Surg       Date:  2001-10       Impact factor: 4.268

4.  Vascular access choice in incident hemodialysis patients: a decision analysis.

Authors:  David A Drew; Charmaine E Lok; Joshua T Cohen; Martin Wagner; Navdeep Tangri; Daniel E Weiner
Journal:  J Am Soc Nephrol       Date:  2014-07-25       Impact factor: 10.121

5.  Vascular access survival among incident hemodialysis patients in the United States.

Authors:  J D Woods; M N Turenne; R L Strawderman; E W Young; R A Hirth; F K Port; P J Held
Journal:  Am J Kidney Dis       Date:  1997-07       Impact factor: 8.860

6.  Arteriovenous fistula outcomes in the era of the elderly dialysis population.

Authors:  Charmaine E Lok; Matthew J Oliver; Jiandong Su; Cynthia Bhola; Neil Hannigan; Sarbjit V Jassal
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

7.  Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas.

Authors:  M J Oliver; R L McCann; O S Indridason; D W Butterly; S J Schwab
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

8.  The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care.

Authors:  Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

9.  Superiority of autogenous arteriovenous hemodialysis access: maintenance of function with fewer secondary interventions.

Authors:  Ganesha B Perera; Mark P Mueller; Stephen M Kubaska; Samuel E Wilson; Peter F Lawrence; Roy M Fujitani
Journal:  Ann Vasc Surg       Date:  2004-01-20       Impact factor: 1.466

Review 10.  Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review.

Authors:  Thomas S Huber; Jeffrey W Carter; Randy L Carter; James M Seeger
Journal:  J Vasc Surg       Date:  2003-11       Impact factor: 4.268

View more
  17 in total

1.  Central Venous Stenosis, Access Outcome and Survival in Patients undergoing Maintenance Hemodialysis.

Authors:  Anamika Adwaney; Charlotte Lim; Sarah Blakey; Neill Duncan; Damien R Ashby
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-14       Impact factor: 8.237

Review 2.  New Insights into Dialysis Vascular Access: What Is the Optimal Vascular Access Type and Timing of Access Creation in CKD and Dialysis Patients?

Authors:  Karen Woo; Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

3.  Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study.

Authors:  Kenneth J Woodside; Sarah Bell; Purna Mukhopadhyay; Kaitlyn J Repeck; Ian T Robinson; Ashley R Eckard; Sudipta Dasmunshi; Brett W Plattner; Jeffrey Pearson; Douglas E Schaubel; Ronald L Pisoni; Rajiv Saran
Journal:  Am J Kidney Dis       Date:  2018-02-09       Impact factor: 8.860

4.  Variations in outcomes of hemodialysis vascular access by race/ethnicity in the elderly.

Authors:  Karen Woo; Laura Gascue; Dana P Goldman; John A Romley
Journal:  J Vasc Surg       Date:  2016-12-24       Impact factor: 4.268

Review 5.  New Frontiers in Vascular Access Practice: From Standardized to Patient-tailored Care and Shared Decision Making.

Authors:  Mariana Murea; Karen Woo
Journal:  Kidney360       Date:  2021-06-15

6.  The Survival Benefit of "Fistula First, Catheter Last" in Hemodialysis Is Primarily Due to Patient Factors.

Authors:  Robert S Brown; Bhanu K Patibandla; Alexander S Goldfarb-Rumyantzev
Journal:  J Am Soc Nephrol       Date:  2016-09-07       Impact factor: 10.121

7.  The Impact of Frailty on the Outcomes of Hemodialysis Vascular Access.

Authors:  Chiu-Hui Chen; Yu-Ling Hsieh; Shao-Yuan Chuang; Fan-Yin Su; Kuan-Ting Wang; Chien-Ming Luo; Shih-Wei Meng; Chih-Cheng Wu
Journal:  Acta Cardiol Sin       Date:  2022-01       Impact factor: 2.672

Review 8.  The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology.

Authors:  Carlo Lomonte; Giacomo Forneris; Maurizio Gallieni; Luigi Tazza; Mario Meola; Massimo Lodi; Massimo Senatore; Walter Morale; Monica Spina; Marcello Napoli; Decenzio Bonucchi; Franco Galli
Journal:  J Nephrol       Date:  2016-01-16       Impact factor: 3.902

Review 9.  Treatment decisions for older adults with advanced chronic kidney disease.

Authors:  Steven J Rosansky; Jane Schell; Joseph Shega; Jennifer Scherer; Laurie Jacobs; Cecile Couchoud; Deidra Crews; Matthew McNabney
Journal:  BMC Nephrol       Date:  2017-06-19       Impact factor: 2.388

10.  The patient experience of hemodialysis vascular access decision-making.

Authors:  Karen Woo; Huibrie Pieters
Journal:  J Vasc Access       Date:  2020-10-29       Impact factor: 2.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.